Expression and localization of thymidine phosphorylase/platelet-derived endothelial cell growth factor in skin and cutaneous tumors

Journal of Cutaneous Pathology

Volumn 26, Issue 6, 1999, Pages 287-294

  Asgari, Maryam M ^a,b   Haggerty, John G ^a,b   McNiff, Jennifer M ^a,b   Milstone, Leonard M ^a,b   Schwartz, Pauline M ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; THYMIDINE PHOSPHORYLASE;

ARTICLE; BASAL CELL CARCINOMA; BASEMENT MEMBRANE; CELL DIFFERENTIATION; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; EPIDERMIS; HAIR FOLLICLE; HAIR ROOT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFUNDIBULUM; KERATINOCYTE; MELANOMA; MERKEL CELL TUMOR; NEVUS; PROTEIN EXPRESSION; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; STAINING; SWEAT GLAND; SYRINGOMA; TISSUE DISTRIBUTION;

ANTIBODY SPECIFICITY; CELL SIZE; HAIR FOLLICLE; HUMANS; IMMUNOENZYME TECHNIQUES; KERATINOCYTES; SKIN; SKIN NEOPLASMS; THYMIDINE PHOSPHORYLASE; TUMOR CELLS, CULTURED;

EID: 0032783755     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1999.tb01846.x     Document Type: Article

References (45)

1. 1. Schwartz PM, Reuveni H, Milstone LM. Local and systemic implications of thymidine catabolism by human keratinocytes. Ann NY Acad Sci 1988; 548: 115.
2. 2. Shaw T, Smillie RH, MacPhee DG. The role of blood platelets in nucleoside metabolism: Assay, cellular location and significance of thymidine phosphorylase in human blood. Mut Res 1988; 200: 99.
3. 3. Lee SS, Giovanella BC, Stehlin, JS Jr. Selective lethal effects of thymidine on human and mouse tumor cells. J Cell Physiol 1977; 92: 401.
4. 4. Furukawa T, Yoshimura A, Sumizawa T, et al. Angiogenic factor. Nature 1992; 356: 668.
5. 5. Usuki K, Saras J, Waltenberger J, et al. Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. Biochem Biophys Res Comm 1992; 184: 1311.
6. 6. Miyazono K, Okabe T, Urabe A, Takaku F, Heldin CH. Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem 1987; 262: 4098.
7. 7. Usuki K, Heldin N-E, Miyazono K, et al. Production of platelet-derived endothelial cell growth factor by normal and transformed human cell in culture. Proc Natl Acad Sci USA 1989; 86: 7427.
8. 8. Ishikawa F, Miyazono K, Hellman U, et al. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 1989; 338: 557.
9. 9. Haraguchi M, Miyadera K, Uemura K, et al. Angiogenic activity of enzymes. Nature 1994; 368: 194.
10. 10. Moghaddam A, Zhang H-T, Fan T-PD, et al. Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci USA 1995; 92: 998.
11. 11. Miyadera K, Sumizawa T, Haraguchi M, et al. Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res 1995; 55: 1687.
12. 12. Yoshimura A, Kuwazuru Y, Furukawa T, Yoshida H, Yamada K, Akiyama S-I. Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors. Biochim Biophys Acta 1990; 1034: 107.
13. 13. Fox SB, Moghaddam A, Westwood M, et al. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: An immunohistochemical study. J Pathol 1995; 176: 183.
14. 14. Schwartz PM, Milstone LM. Thymidme phosphorylase in human epidermal keratinocytes. Biochem Pharmacol 1988; 37:353.
15. 15. Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H, Tominaga T. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int J Cancer 1995; 64:79.
16. 16. Fox SB, Westwood M, Moghaddam A, et al. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br J Cancer 1996; 73: 275.
17. 17. Takebayashi Y, Yamada K, Miyadera K, et al. The activity and expression of thymidine phosphorylase in human solid tumors. Eur J Cancer 1996; 32A: 1227.
18. 18. O'Brien TS, Fox SB, Dickinson AJ, et al. Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Res 1996; 56: 4799.
19. 19. Giatromanolaki A, Koukourakis MI, Comley M, et al. Platelet-derived endothelial cell growth factor (thymidine phosphorylase) expression in lung cancer. J Pathol 1997; 101: 196.
20. 20. Maeda K, Chung YS, Ogawa Y, et al. Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer 1996; 73: 884.
21. 21. Schwartz PM, Barnett SK, Reuveni H. Thymidine salvage changes with differentiation in human keratinocytes in vitro. J Invest Dermatol 1991; 97: 1057.
22. 22. Schwartz PM, Kugelman LC, Coifman Y, Hough LM, Milstone LM. Human keratinocytes catabolize. J Invest Dermatol 1988; 90: 8.
23. 23. Creamer D, Jaggar, R., Allen M, Bicknell R, Barker J. Overexpression of the angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase in psoriatic epidermis. Br J Dermatol 1997; 137: 851.
24. 24. Hammerberg C, Fisher GJ, Voorhees JJ, Cooper KD. Elevated thymidine phosphorylase activity in psoriatic lesions accounts for the apparent presence of an epidermal "growth inhibitor," but is not in itself growth inhibitory. J Invest Dermatol 1991; 97; 286.
25. 25. Haggerty JH, Bretton RH, Milstone LM. Identification and characterization of a cell surface protcoglycan on keratinocytes. J Invest Dermatol 1992; 99: 374.
26. 26. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350.
27. 27. Böhm M, Moellmann G, Cheng E, et al. Identification of p90RSK as the probable CREB-SER133 kinase in human metanocytes. Cell Growth Differ 1995; 6: 291.
28. 28. Reiss M, Sartorelli AC. Regulation of growth and differentiation of human keratinocytes by type β transforming growth factor and epithelial growth factor. Cancer Res 1987; 47: 6705.
29. 29. Teumer J, Zezulak K, Green H. Isolation of RNA from keratinocytes of different sixes fractionated by elutriation. In: Leigh I, Watt F, eds. Keratinocyte Methods, Cambridge; Cambridge University Press, 1994: 99.
30. 30. Watt FM, Green H. Involucrin synthesis is correlated with cell size in human epidermal cultures. J Cell Biol 1981; 90: 738.
31. 31. Harmenberg J, Abele G, Malm M. Deoxythymidine pools in animal and human skin with reference to antiviral drugs. Arch Dermatol Res 1985; 277: 402.
32. 32. Stevenson DP, Milligan SR, Collins WP. Effects of platelet-derived endothelial cell growth factor/thymidine phosphorylase, substrate, and products in a three-dimensional model of angiogenesis. Am J Path 1998; 152: 1641.
33. 33. Brown NS, Bicknell R. Thymidine phosphorylase, 2-deoxyribose and angiogenesis. Biocehem J 1998; 331: 1.
34. 34. Folkman J. What is the role of thymidine phosphorylase in tumor angiogenesis? J Natl Cancer Inst 1996; 88: 1091.
35. 35. Toi M, Taniguchi T, Yamamoto Y, Kurisaki T, Suzuki H, Tominaga T. Clinical significance of the determination of angiogenic factors. Eur J Cancer 1996; 32A: 2513.
36. 36. Nishimoto K, Miyaders K, Takebayashi Y, et al. Thymidine phosphorylase activity required for tumor angiogenesis and growth. Oncol Repts 1997; 4: 55.
37. 37. Leyva A, Appel H, Kraal I, Pinedo HM. Differential metabolism of thymidine in human lymphoid and melanoma cells in vitro. Anticancer Res 1984; 4: 173.
38. 38. Asgari MM, Madison-McNiff, JF, Milstone LM, Schwartz PM. Expression of platelet derived endothelial cell growth factor/thymidine phosphorylase in skin tumors. J Invest Dermatol 1998; 110: 628.
39. 39. Creamer D, Allen M, Bicknell R, Barker J. Variable expression of the angiogenic factor, thymidine phosphorylase in non-melanoma skin cancer [Abstract]. J Invest Dermatol 1998; 110: 523.
40. 40. Zackheim HS. Origin of the human basal cell epithelioma. J Invest Dermatol 1963; 40: 283.
41. 41. Schirren CG, Rutten A, Kaudewitz P, Diaz C, McClain S, Burgdorf WH. Trichoblastoma and basal cell carcinoma are neoplasms with follicular differentiation sharing the same profile of cytokeratin intermediate filaments. Am J Dermatopathol 1997; 19: 341.
42. 42. Johnson RL, Rothman AL, Xie J, et al. Human homologue of patched, a candidate gene for the basal cell nevus syndrome. Science 1996; 272: 1668.
43. 43. Unden AB, Zaphiropouls PG, Bruce K, Toftgard R, Stahle-Backdahl. Human patched (PTCH) mRNA is overexpressed consistently in tumor cells of both familial and sporadic basal cell carcinomas. Cancer Res 1997; 57: 2236.
44. 44. Kallassy M, Toftgard R, Ueda M, et al. Patched (ptch)-associated preferential expression of smoothened (smoh) in human basal cell carcinoma of the skin. Cancer Res 1997; 57: 4731.
45. 45. Weninger Q, Rendl M, Pammer J, Grin W, Petzelbauer P, Tschachler E. Differences in tumor microvessel density between squamous cell carcinomas and basal cell carcinomas may relate to their biologic behavior. J Cutan Pathol 1997; 24: 364.